News and Stories About Precision Promise
The Bold Path to PanCAN’s Precision PromiseSM Clinical Trial
We recently announced that our groundbreaking new approach to pancreatic cancer clinical trials – PanCAN’s Precision PromiseSM – is open […]
READ MORE
Pancreatic Cancer Action Network Announces Groundbreaking Clinical Trial Platform Transforming Development of Treatment Options for World’s Toughest Cancer
Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials Los Angeles, Calif. […]
READ MORE
PanCAN’s Precision PromiseSM Clinical Trial Is Open, Enrolling Patients
“The standard clinical trial system is not working fast enough for pancreatic cancer patients.” — Julie Fleshman, JD, MBA, PanCAN […]
READ MORE
PanCAN’s Annual Scientific Summit Goes Virtual
The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit may have looked different this year, but some things stayed the […]
READ MORE
Accelerating Personalized Care for Pancreatic Cancer Patients
“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE
2019 Year in Review: Progress in Research
Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE
Experts Discuss Adaptive Platform Clinical Trials
Clinical trials are necessary to determine whether a drug or treatment combination is safe, effective and an improvement over the […]
READ MORE
PanCAN President and CEO Shares Highlights from Esteemed Precision Medicine Roundtable
Editor’s note: Pancreatic Cancer Action Network (PanCAN) President and CEO Julie Fleshman attended the Harvard Business School (HBS) Kraft Precision […]
READ MORE
Precision Promise Spotlighted at International Conference
The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) took place earlier this week in Berlin. The […]
READ MORE
Innovation in Action: Precision Promise Update
The Pancreatic Cancer Action Network (PanCAN) is excited to launch Precision PromiseSM in 2019. Precision Promise is the first adaptive […]
READ MORE
Largest Gift in PanCAN History Is a Powerful Testament to Donor’s Commitment to Innovation, Impact
Entrepreneur Skip Viragh was a collaborator. An innovator. A proactive problem-solver. A masterful leader. And he deeply valued these qualities […]
READ MORE
Pancreatic Cancer in U.S. News & World Report
“Let’s face it: The pancreas is a behind-the-scenes organ most of us don’t know – or think – much about. […]
READ MORE
Tempus Invests in Innovative Cancer Technology
Congratulations to Pancreatic Cancer Action Network (PanCAN) partner Tempus, a technology company building the world’s largest library of molecular and […]
READ MORE
Medscape Highlights Pancreatic Cancer and Precision PromiseSM in Recent Feature
Yesterday, Medscape published a feature story detailing the science behind pancreatic cancer. The article recounts the devastating statistics of the […]
READ MORE
Meet Dr. Vince Picozzi, Chair of the Precision Promise Clinical Trial Consortium
Meet Vincent Picozzi, Jr., MD, director of the pancreaticobiliary program at the Floyd & Delores Jones Cancer Institute at Virginia […]
READ MORE
Get to Know our New Chief Medical Officer, Victoria Manax Rutson, MD
Last month we welcomed Victoria Manax Rutson, MD, to our team as our first Chief Medical Officer! The need for […]
READ MORE
The Leading Doctors behind Precision Promise
Earlier this week we announced Precision Promise, the first large-scale precision medicine trial that will put the patient at the […]
READ MORE
Our Promise to Pancreatic Cancer Patients
Today is a milestone for our organization and the pancreatic cancer community. We have made a promise to transform outcomes […]
READ MORE
